It has been suggested that RPL23A and HIST2H2BE play a central role in the progression from normal liver cells to PBC&PSC, so we propose that RPL23A and HIST2H2BE are potential drug targets that might overcome the defects in autoimmunity and the subsequent dysfunction in metabolism. Here, RPL23A is linked to primary biliary cholangitis.